Achieve Life Sciences
ACHV
ACHV
33 hedge funds and large institutions have $14.6M invested in Achieve Life Sciences in 2022 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 7 increasing their positions, 8 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
2% less capital invested
Capital invested by funds: $14.9M → $14.6M (-$296K)
13% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 8
Holders
33
Holding in Top 10
–
Calls
$718K
Puts
$120K
Top Buyers
| 1 | +$339K | |
| 2 | +$131K | |
| 3 | +$97.7K | |
| 4 |
Simplex Trading
Chicago,
Illinois
|
+$90.4K |
| 5 |
Charles Schwab
San Francisco,
California
|
+$76.7K |
Top Sellers
| 1 | -$362K | |
| 2 | -$148K | |
| 3 | -$143K | |
| 4 |
Two Sigma Advisers
New York
|
-$35.5K |
| 5 |
SC
Shay Capital
New York
|
-$32.4K |